Drug Development
Providers using this tag (136)
Ranked by API Evangelist rating — Exemplar and Strong are expanded by default.
Developing 1 Usable, with meaningful gaps to close
Thin 1 Limited public surface area
Emerging 21 Early or largely undocumented
Engrail TherapeuticsEndeavor BioMedicinesAlloplex BiotherapeuticsAbcuroADARx PharmaceuticalsBioAegis TherapeuticsArbor BiotechnologiesVeradermicsChampions OncologyQUIBIMNacuity PharmaceuticalsZetagen TherapeuticsBluejay TherapeuticsAlzheonActym TherapeuticsTilda ResearchEnjamb LabsVedanta BiosciencesLEAF4LifeQurAlisImbria Pharmaceuticals
Minimal 110 Almost no public developer surface
Biosplice TherapeuticsAdlai NortyeKirilys TherapeuticsAttralusAlpha-9 OncologyDren BioFrontage LaboratoriesTigermedAlectorAngitia BiopharmaceuticalsTransposon TherapeuticsArriVentCardurion PharmaceuticalsEvommuneLatus BioRivus PharmaceuticalsSidewinder TherapeuticsUpstream BioZag BioantengeneBasking BiosciencesBitterroot BioCour Pharmaceuticals DevelopmentLENZ TherapeuticsSpero TherapeuticsTriveni BioAardvark TherapeuticsCreyon BioRevalia BioRoivantInovia BioOllin BioSionna TherapeuticsAngiexPathosAverna TherapeuticsPharmaronAgomab TherapeuticsFormation BioAutobahn TherapeuticsCambrian BioLB PharmaceuticalsPhaseVAshvattha TherapeuticsCelerion (H.I.G. Capital)Abogen BiosciencesCandid TherapeuticsConvokePulmocideCarrick TherapeuticsSynthekine35PharmaAlumisBraveheart BioReven PharmaceuticalsPheon TherapeuticsAvistoneOrchestraBiorchestraImmune-Onc TherapeuticsAnsun BiopharmaRed RidgeBioAsymchemAusperBioOrsoBioArk BiopharmaceuticalBeiGenecnCovance (Fortrea)Dizal PharmaNovotechPharmazzShasqiDenali TherapeuticsElion TherapeuticsDvlp MedicinesAiolos BioCatalYmaceatherapeuticsacxelAllena PharmaceuticalsApollomicsComanche BiopharmaCorsair PharmaImmunos TherapeuticskechowpharmaMetsera *Nocion TherapeuticsPerceive BioSpyBiotechMendraAbdera TherapeuticsArthrosi TherapeuticsBambusa TherapeuticsBoyuan PharmAcesion Pharmaimmune-pathKelun-BiotechMinghui PharmaceuticalMycoMedicaNextcurenovamabPeninsula PharmaceuticalsConcentric AnalgesicsCapacity BioCell PathwaysDurata TherapeuticsEQRxFaraday PharmaceuticalsIterum Therapeutics
Unrated 3 Not yet scored
APIs with this tag (0)
No API pages are linked for this tag yet. Search apis.io →
Score breakdown
Frequency
58.7
log-scaled weighted occurrences
Breadth
3.5
spread across providers
Quality lift
10.0
mean composite of providers using it
Cohesion
0.0
strength of nearest seed neighbor
Where this tag sits
136 providers carry this tag directly, and 677 counting the 2 narrower tags below and the 2 beneath them — 541 more to reach.
Related tags
Biopharmaceutical 35 co-occurrences
Pharmaceuticals 95 co-occurrences
Clinical Trials 57 co-occurrences
Biotechnology 112 co-occurrences
Immunology 21 co-occurrences
Life Sciences 107 co-occurrences
Oncology 33 co-occurrences
Clinical Stage 14 co-occurrences
Where this tag comes from
Provider tag136
Cohort brief
Auto-generatedThe 112 providers in the APIs.io catalog tagged Drug Development, scored on the Kin Score. Every figure below is computed from the catalog — nothing here is written.
Providers
112
of 136 in the catalog
Mean Kin Score
9
-13.9 vs catalog 22.9
Mean Agent Readiness
1.8
-10.1 vs catalog 11.9
Spread
0–41.8
median 8.6 · σ 5.9
How the 112 split by band
Exemplar 0Strong 0Developing 1Thin 1Emerging 21Minimal 89
Facet averages, against the whole catalog
| Facet | This cohort | Catalog | Difference | Scored |
|---|---|---|---|---|
| Contract Governance | 1.8 | 6.3 | -4.5 | 112 |
| Discoverability | 51.1 | 58.1 | -7 | 112 |
| Operational Transparency | 0.4 | 13.7 | -13.3 | 112 |
| Access Clarity | 12.3 | 26.5 | -14.2 | 112 |
| Contract Quality | 0.9 | 17.6 | -16.7 | 112 |
| Developer Ergonomics | 6.5 | 23.2 | -16.7 | 112 |
A facet is averaged over the members that carry it, not over the whole cohort — the “Scored” column is that count. Averaging an absent facet as zero would score our own coverage gaps as the providers’ posture.
What this cohort publishes
| Artifact | This cohort | Catalog | Difference |
|---|---|---|---|
| MCP server (any) | 6% | 14% | -8 |
| MCP server (first-party) | 3% | 12% | -9 |
| Agent Skills | 0% | 0% | 0 |
| OAuth scopes | 3% | 11% | -8 |
| Security | 97% | 98% | -1 |
| Arazzo workflows | 0% | 2% | -2 |
| Governance rules | 1% | 14% | -13 |
mcp_pct counts any mcp/ artifact including ones API Evangelist derived from the provider OpenAPI; mcp_first_party_pct counts only servers the provider publishes. Prefer the latter.
Top by Kin Score
- 1 Roivant Sciences 41.8
- 2 Orakl 28.8
- 3 Engrail Therapeutics 22
- 4 Endeavor BioMedicines 21.3
- 5 Alloplex Biotherapeutics 20.7
- 6 Abcuro 20.2
- 7 ADARx Pharmaceuticals 20
- 8 BioAegis Therapeutics 18.9
- 9 Arbor Biotechnologies 18.1
- 10 Veradermics 18
Top by Agent Readiness
- 1 Orakl 29
- 2 Roivant Sciences 26.3
- 3 Endeavor BioMedicines 20
- 4 Veradermics 19.1
- 5 Engrail Therapeutics 18.2
- 6 Enjamb Labs 8.6
- 7 Convoke 8.6
- 8 Orchestra 8.6
- 9 Abcuro 8.1
- 10 Actym Therapeutics 7.2
All 136 members of this roster resolve to a provider in the
catalog; 112 carry a score (82%).
The figures above describe the scored members only.
Coverage caveat. 111 of 112 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 5 October 2026, across 29093 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Coverage caveat. 111 of 112 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 5 October 2026, across 29093 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Work with this as data
Every tag here is available over the APIs.io API and to AI agents over MCP.